TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Left Atrial (LA) volumes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Right Ventricular (RV) function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Physical health domain of quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Median visual analogue scale score for all activities
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Self‐evaluated utility visual analogue scale score >7
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Primary prophylaxis failure
Endpoint domain: Adverse events/effects
Primary endpoint: Intraocular Lens (IOL) decentration and tilt
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improving verbal fluency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Alleviating psychiatric symptoms
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Reducing caregiver distress
Endpoint domain: Life impact
Endpoint subdomain: Societal/carer burden
Primary endpoint: patient-reported success rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of intraprocedural hypoventilation
Endpoint domain: Adverse events/effects
Primary endpoint: Passive dorsiflexion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ICU admissions
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Serum S‐ICAM‐1 concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Serum IL‐8 concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Depression subscale score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Area under concentration-time curve (AUC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean urinary nitrogen excretion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Mid-thigh muscle area
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: ΔALSFRS‐R between‐group difference
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: same-day reliability for electrical stimulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decreased activation to cocaine cues
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: MSIS29
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MS-related symptom checklist (MS-RS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lower limb strength (right knee extension and flexion)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: EGFR gene copy number as a predictor of survival
Endpoint domain: Mortality/survival
Primary endpoint: EGFR protein expression related to clinical outcome
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Response rates in patients with EGFR mutations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: disease progression or death
Endpoint domain: Mortality/survival
Primary endpoint: Deformation of abnormal myocardial segments
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Improvement on MPH over placebo
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Risk of attention-deficit/hyperactivity disorder in first-degree relatives
Endpoint domain: Adverse events/effects
Primary endpoint: Risk of antisocial personality disorder in second-degree relatives
Endpoint domain: Adverse events/effects
Primary endpoint: Mild or no pain at 30 minutes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: First Sound Fluency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Word Parts Fluency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: latency to systolic blood pressure recovery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: latency to diastolic blood pressure recovery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Postoperative self‐rated change in reflux symptoms
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Reduction in oesophageal acid exposure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Frequency of heartburn occurring at least once a week
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Frequency of acid regurgitation occurring at least once a week
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Median distance walked in 6 minutes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean pulmonary artery pressure changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Mean pulmonary vascular resistance changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Incidence of orgasm dysfunction at week 8
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Incidence of worsened sexual functioning at the end of the treatment period
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Epithelial expression of IL-5
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: fall prevalence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: recurrent fall prevalence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CGI-SF score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: ASEX score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Affective pain perception
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Copeptin concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 30-day all-cause death, cardiogenic shock, congestive heart failure, and reinfarction
Endpoint domain: Mortality/survival
Primary endpoint: F‐RHI (Flow-mediated dilation)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Cumulative probability of failure at 1 year
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean IOP at 1 year
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean number of glaucoma medications required
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Behavioral Rating Scale of the BSID‐II
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Mean frequency of voids
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Endometriosis-related pain
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: enhanced error monitoring
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: rate of fatal or nonfatal stroke
Endpoint domain: Mortality/survival
Primary endpoint: rate of heart failure
Endpoint domain: Mortality/survival
Primary endpoint: Systolic ABP reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: ionised calcium concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: ionised magnesium concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: sensitivity of point-of-care ultrasound
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: specificity of point-of-care ultrasound
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: FLSI score for flu-like symptoms
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: glycaemic control improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: attendance at clinic appointments
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: physical therapy intervention program completion rate
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: post‐treatment ankle function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decline in SBP and DBP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Effective rate of Benazepril
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: muscle microvascular reoxygenation (O2 Hb)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: resting/ambulatory blood pressure (BP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: peripheral resistance responses during isometric exercise
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Glasgow Coma Scale score decline to less than 14
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Clinically apparent brain injury
Endpoint domain: Adverse events/effects
Primary endpoint: AUC0-infinity of LTG, OXC and MHD
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Tmax of OXC and MHD
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: AUC6-infinity and t1/21beta of LTG
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: VIS levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: morphological awareness abilities
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: reading comprehension abilities
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of respondents who correctly assess post-test probability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Knowledge of anatomy and key terms
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Willingness to consider screening
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Intention to discuss CRC screening with their doctor
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Propofol dose required for laryngeal mask insertion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Pain on injection with propofol
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in mean thyroid volume (SDS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Asymptomatic bacteriuria
Endpoint domain: Adverse events/effects
Primary endpoint: Arthroplasty infection after 3 months
Endpoint domain: Adverse events/effects
Primary endpoint: Signs of PJI by 1 year
Endpoint domain: Adverse events/effects
Primary endpoint: average modified objective pain scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: average behavior score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: neck pain scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: retching frequency
Endpoint domain: Adverse events/effects
Primary endpoint: RMP bioavailability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Perceived state of anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: mean clinical scores of postural tremor
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: mean clinical scores of kinetic tremor
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: mean tremor amplitude reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: HBeAg undetectability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of un-precipitated AKI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: incidence of primary postoperative ileus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Pretreatment ADC as a biomarker for predicting IC response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Median severity of pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AIDS knowledge
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Intention to practice HIV preventive behaviors
Endpoint domain: Life impact
Endpoint subdomain: Behavioral outcomes
Primary endpoint: Physical outcome motivation
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Social outcome motivation
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Wound temperature
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: horizontal loss in hard tissue over implant platform
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean recession of buccal soft tissue
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: serum total bilirubin level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: per capita cost of treatment
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Standard deviation of blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Severity scores for burning, itching and erythema
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Blood pressure fall
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: decrease of vancomycin concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: decrease of meropenem concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Embryo cleavage rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: opioid-related side effects
Endpoint domain: Adverse events/effects
Primary endpoint: rate of tumor regression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: rate of severe side effects
Endpoint domain: Adverse events/effects
Primary endpoint: e'/a' ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Trp levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Kyn levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: patient comfort level
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: TEWL improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: buccal mucosal bleeding times
Endpoint domain: Adverse events/effects
Primary endpoint: hopping and conscious proprioception
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: ovarian weights
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Dose-limiting toxicities (DLT)
Endpoint domain: Adverse events/effects
Primary endpoint: Target trough concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: percentage change in vein diameter
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Re-tear rate
Endpoint domain: Adverse events/effects
Primary endpoint: Difference in weight
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: rate of repeat interventions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Mean absolute increase of 25(OH)D at 6 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of participants reaching 25(OH)D≥30 ng/mL
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: recurrence rate of shoulder dislocations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement of infectious and febrile syndromes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Reduction of serum IL-1b concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Rett Syndrome Behaviour Questionnaire
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: RTT‐Clinician Domain Specific Concerns‐Visual Analog Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical Global Impression Scale‐Improvement
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Ranking of teaching models
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mask ventilation success
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Realism in laryngeal mask airway insertion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Speech comprehensibility
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increase of terminal complement complex (TCC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: F(ET)O(2) > or = 90%
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decrease in rheumatoid factor levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Decrease in cryocrit levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Cough sleep disruption
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of life scores (LCQ-acute)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Time to Return to Work (RTW)
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Rate of improvement at maximum brow elevation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Rate of relapse to baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Incidence of postoperative clinical infection
Endpoint domain: Adverse events/effects
Primary endpoint: Bacterial colony count in the stone culture
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: VAS score of nonsurgical wound pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in C-peptide levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Decrease in homeostasis model assessment of insulin resistance index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: mortality due to liver failure
Endpoint domain: Mortality/survival
Primary endpoint: Correctly answered fire and burn prevention knowledge questions
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Demonstrated safety skills
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: K Max
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CDVA (logMAR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Standard Deviation of Normal Intervals (SDNN)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Self-regulated learning of preschool children
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: body temperature recovery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: wind-breaking time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: changes of tongue coating
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: stone-free rate at 6 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: interval to stone passage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: number of episodes of pain experienced
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean lifespan
Endpoint domain: Mortality/survival
Primary endpoint: Mean adherence measured by Travalert dosing aid
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quantification of remifentanil in human whole blood
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cumulative relative reduction in ulcer area
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Relative reduction in wound area
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: decrease in the number of flushes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes